TIS 0.00% 0.0¢ tissue therapies limited

Capital raise, page-22

  1. 773 Posts.
    lightbulb Created with Sketch. 4
    I'm impressed by the investor presentation and by the input that Christian is clearly making....no doubt this was largely written by him.

    So we have a company with the right leadership, sufficient funding, a competitive product for the market segments identified, at a very low market cap.

    Seems there's very little downside risk, really good potential, and an end to the catastrophic previous management culture. I'm looking to buy. (Again, I was in a few years back but gave up after the endless errors and confusion)
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.